Enter assignee name

EPO Patents = 2

Trademarks = 2

Forward Citations = 6

Loading Chart...

6 inventors (with patents filed for the assignee):

Uriel Halavee (9 out of 12 patents)

Natalie Yivgi-Ohana (5 out of 5 patents)

Shmuel Bukshpan (5 out of 12 patents)

4. Moriya Blumkin (4 out of 4 patents)

5. Noa Sher (4 out of 4 patents)

6. Natalie Yivgi Ohana (4 out of 4 patents)

9 patents: Sort by Forward Citations

1. 12440515 - Mitochondrial augmentation therapy of brain diseases (2025-10-14),

2. 12329781 - Mitochondrial augmentation therapy of renal diseases (2025-06-17),

3. 12239672 - Mitochondrial augmentation therapy of ocular diseases (2025-03-04),

4. 11951135 - Mitochondrial augmentation therapy of muscle diseases (2024-04-09),

5. 11944642 - Compositions of functional mitochondria and uses thereof (2024-04-02),

6. 11441124 - Mammalian cells enriched with functional mitochondria (2022-09-13),

7. 11351195 - Compositions of functional mitochondria and uses thereof (2022-06-07),

8. 10702556 - Compositions and methods for inducing angiogenesis (2020-07-07),

9. 10213459 - Compositions of functional mitochondria and uses thereof (2019-02-26),

Minovia Therapeutics is a biotechnology company focused on developing novel therapies for mitochondrial diseases. The company's proprietary technology platform enables the identification and development of small molecules that target mitochondrial dysfunction. Minovia's lead candidate is currently in preclinical development for the treatment of rare genetic mitochondrial diseases. The company is dedicated to bringing innovative treatments to patients with unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

9 Patents

#32 in Rehovot

#674 in Israel

Rehovot, Israel

Minovia Therapeutics Ltd.